Latest filing published 13 May 2025 for 方盛制药, €484k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +11.3%Entry CN¥9.61 · Close at T+365 CN¥10.70
- +31.4%Entry CN¥9.50 · Close at T+365 CN¥12.48
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
张祖嵘: trading record in brief
张祖嵘, listed as chief executive, appears in our data through filings on 方盛制药 shares, published by SSE / SZSE (CSRC). Over a trading history stretching from 11 February 2025 to 13 May 2025, the count stands at 2 filings.
On the market, this insider has only ever bought: 2 purchases, €497k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
The record was last updated on 13 May 2025 with an open-market purchase (€484k) in 方盛制药. Every figure here comes from the filings published by SSE / SZSE (CSRC) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to 张祖嵘
Open company profiles for insider transactions, fundamentals and analyst consensus when available.